Daiichi Sankyo
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Daiichi Sankyo
RECRUITINGPhase 1NCT06644755
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
This 2-part study will evaluate safety, tolerability, and clinical efficacy of DS-2243a as a treatment for participants with advanced solid tumors.
Sponsor: Daiichi SankyoEnrolling: 1507 locations
Solid TumorsSarcoma
RECRUITINGPhase 2 / Phase 3NCT07129993
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in...
This is a global, multicenter, randomized, open-label, Phase 2/3 study of Dato-DXd plus carboplatin or cisplatin versus gemcitabine plus carboplatin or cisplatin in participants...
Sponsor: Daiichi SankyoEnrolling: 63020 locations
Urothelial CancerBladder Cancer